The Leeds Assessment of Neuropathic Symptoms and Signs Scale (LANSS) is not an adequate outcome measure of pressure ulcer-related neuropathic pain

被引:3
|
作者
Rutherford, C. [1 ,2 ]
Nixon, J. E. [2 ]
Brown, J. M. [2 ]
Briggs, M. [3 ]
Horton, M. [4 ]
机构
[1] Univ Sydney, Sch Psychol, Sydney, NSW 2006, Australia
[2] Univ Leeds, Leeds Inst Clin Trials Res, Leeds, W Yorkshire, England
[3] Leeds Metropolitan Univ, Inst Hlth & Well Being, Leeds, W Yorkshire, England
[4] Univ Leeds, Psychometr Lab Hlth Sci, Leeds, W Yorkshire, England
关键词
QUALITY-OF-LIFE; RASCH MEASUREMENT MODEL; CLINICAL-TRIALS; COEFFICIENT; IMPACT;
D O I
10.1002/ejp.894
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
BackgroundFew pain assessment scales have been used in pressure ulcer (PU) research and none developed or validated for people with PUs. We examined the Leeds Assessment of Neuropathic Symptoms and Signs (LANSS) scale to determine its utility as an outcome measure for people with pressure area-related pain. MethodsLeeds Assessment of Neuropathic Symptoms and Signs data from 728 participants underwent psychometric analyses: traditional tests for data quality, scaling assumptions, reliability and validity and a Rasch analysis including tests of fit, spread and targeting of item locations, response dependency, person separation index (reliability) and differential item functioning. ResultsOur findings offer support for a unidimensional scale; confirmatory factor analysis indicated a non-significant chi-square test of model fit [(df=14) 23.48, p=0.053]. However, some misfit was identified at the overall scale and individual item levels, and internal construct validity of the LANSS as an outcome measure for neuropathic pain in people with pressure area-related pain was not supported; low to moderate item-total correlations [Chi Square (df=28) 55.546, p=0.002] and inter-item correlations (mean 0.117 and range from 0.063 to 0.415); and low Cronbach's alpha (0.549) and Person Separation Index (0.334). ConclusionsRequirements for reliable and valid measurement do not support the use of the LANSS as an outcome measure in people with PUs at the individual level or as a generalized measurement scale of neuropathic pain across ulcer severity groups. Expanding the number of items to aid differentiation between neuropathic pain levels and improving scale reliability is recommended. What does this study add?The Leeds Assessment of Neuropathic Symptoms and Signs scale (LANSS) is not suitable as an outcome measure of pressure ulcer-related neuropathic pain as it did not meet requirements for reliable and valid measurement in this population.
引用
收藏
页码:1710 / 1720
页数:11
相关论文
共 35 条
  • [1] The LANSS Pain Scale: the Leeds assessment of neuropathic symptoms and signs
    Bennett, M
    [J]. PAIN, 2001, 92 (1-2) : 147 - 157
  • [2] Linguistic adaptation and Spanish validation of the LANSS (Leeds Assessment of Neuropathic Symptoms and Signs) scale for the diagnosis of neuropathic pain
    Pezez, Concepcion
    Galvez, Rafael
    Insausti, Joaquin
    Bennett, Michael
    Ruiz, Manuel
    Rejas, Javier
    [J]. MEDICINA CLINICA, 2006, 127 (13): : 485 - 491
  • [3] Cross-Cultural Psychometric Assessment of the Leeds Assessment of Neuropathic Symptoms and Signs (LANSS) Pain Scale in the Portuguese Population
    Barbosa, Margarida
    Bennett, Michael I.
    Verissimo, Ramiro
    Carvalho, Davide
    [J]. PAIN PRACTICE, 2014, 14 (07) : 620 - 624
  • [4] Translation, Cultural Adaptation, and Validation of Leeds Assessment of Neuropathic Symptoms and Signs (LANSS) and Self-Complete Leeds Assessment of Neuropathic Symptoms and Signs (S-LANSS) Questionnaires into the Greek Language
    Batistaki, Chrysanthi
    Lyrakos, George
    Drachtidi, Kalliopi
    Stamatiou, Georgia
    Kitsou, Maria-Chrysanthi
    Kostopanagiotou, Georgia
    [J]. PAIN PRACTICE, 2016, 16 (05) : 552 - 564
  • [5] Translation and cultural adaptation of the Leeds Assessment of Neuropathic Symptoms and Signs (LANSS) pain scale into Arabic for use with patients with diabetes in Libya
    Garoushi, Sabri
    Johnson, Mark I.
    Tashani, Osama A.
    [J]. LIBYAN JOURNAL OF MEDICINE, 2017, 12
  • [6] Identifying neuropathic pain in patients with head and neck cancer: use of the Leeds Assessment of Neuropathic Symptoms and Signs Scale
    Potter, J
    Higginson, IJ
    Scadding, JW
    Quigley, C
    [J]. JOURNAL OF THE ROYAL SOCIETY OF MEDICINE, 2003, 96 (08) : 379 - 383
  • [7] Results of the Leeds Assessment of Neuropathic Symptoms and Signs pain scale in Turkey: A validation study
    Yucel, A
    Senocak, M
    Orhan, EK
    Cimen, A
    Ertas, M
    [J]. JOURNAL OF PAIN, 2004, 5 (08): : 427 - 432
  • [8] Validation of the Leeds Assessment of Neuropathic Symptoms and Signs (LANSS) questionnaire and its correlation with visual analog pain scales in Greek population
    Spanos, Konstantinos
    Lachanas, Vasileios A.
    Chan, Philip
    Bargiota, Alexandra
    Giannoukas, Athanasios D.
    [J]. JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2015, 29 (08) : 1142 - 1145
  • [9] Identifying neuropathic pain among patients with chronic low-back pain: Use of the Leeds Assessment of Neuropathic Symptoms and Signs pain scale
    Kaki, AM
    El-Yaski, AZ
    Youseif, E
    [J]. REGIONAL ANESTHESIA AND PAIN MEDICINE, 2005, 30 (05) : 422 - 428
  • [10] Validity and reliability of the Spanish-language version of the self-administered Leeds Assessment of Neuropathic Symptoms and Signs (S-LANSS) pain scale
    Lopez-de-Uralde-Villanueva, I.
    Gil-Martinez, A.
    Candelas-Fernandez, P.
    de Andres-Ares, J.
    Beltran-Alacreu, H.
    La Touche, R.
    [J]. NEUROLOGIA, 2018, 33 (08): : 505 - 514